Clinical trial
Pivotal Phase, Randomised Controlled Trial to Demonstrate a Reduction in the Number of Oliguria Events in Patients Being Managed in a Critical Care Unit, Following Cardiac Surgery, When a Novel Oliguria Prediction Tool (STABILITY UO) is Used to Identify Patients at Risk, Compared to Standard of Care.
NCT05001503 is registered in ClinicalTrials.gov with Rinicare Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pivotal Phase, Randomised Controlled Trial to Demonstrate a Reduction in the Number of Oliguria Events in Patients Being Managed in a Critical Care Unit, Following Cardiac Surgery, When a Novel Oliguria Prediction Tool (STABILITY UO) is Used to Identify Patients at Risk, Compared to Standard of Care.
- Lead sponsor
- Rinicare Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2022
- Completion date
- June 30, 2023
- Enrollment
- 362 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.